Anthony K Blair - Net Worth and Insider Trading
Anthony K Blair Net Worth
The estimated net worth of Anthony K Blair is at least $26,400 dollars as of 2024-05-25. Anthony K Blair is the COO of Zomedica Corp and owns about 150,000 shares of Zomedica Corp (ZOM) stock worth over $26,400. Anthony K Blair is also the VP-Manufacturing & Operations of Navidea Biopharmaceuticals Inc and owns about 1,927 shares of Navidea Biopharmaceuticals Inc (NAVB) stock worth over $0. Details can be seen in Anthony K Blair's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Anthony K Blair has not made any transactions after 2024-05-13 and currently still holds the listed stock(s).
Transaction Summary of Anthony K Blair
Anthony K Blair Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Anthony K Blair owns 2 companies in total, including Navidea Biopharmaceuticals Inc (NAVB) , and Zomedica Corp (ZOM) .
Click here to see the complete history of Anthony K Blair’s form 4 insider trades.
Insider Ownership Summary of Anthony K Blair
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
NAVB | Navidea Biopharmaceuticals Inc | 2011-05-27 | VP-Manufacturing & Operations |
ZOM | Zomedica Corp | 2024-05-13 | Chief Operating Officer |
Anthony K Blair Latest Holdings Summary
Anthony K Blair currently owns a total of 2 stocks. Among these stocks, Anthony K Blair owns 150,000 shares of Zomedica Corp (ZOM) as of May 13, 2024, with a value of $26,400 and a weighting of 100%. Anthony K Blair also owns 1,927 shares of Navidea Biopharmaceuticals Inc (NAVB) as of May 27, 2011, with a value of $0 and a weighting of 0%.
Latest Holdings of Anthony K Blair
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ZOM | Zomedica Corp | 2024-05-13 | 150,000 | 0.18 | 26,400 |
NAVB | Navidea Biopharmaceuticals Inc | 2011-05-27 | 1,927 | 0.00 | 0 |
Holding Weightings of Anthony K Blair
Anthony K Blair Form 4 Trading Tracker
According to the SEC Form 4 filings, Anthony K Blair has made a total of 1 transactions in Zomedica Corp (ZOM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Zomedica Corp is the acquisition of 150,000 shares on May 13, 2024, which cost Anthony K Blair around $21,000.
According to the SEC Form 4 filings, Anthony K Blair has made a total of 0 transactions in Navidea Biopharmaceuticals Inc (NAVB) over the past 5 years. The most-recent trade in Navidea Biopharmaceuticals Inc is the sale of 2,500 shares on May 27, 2011, which brought Anthony K Blair around $261,000.
Insider Trading History of Anthony K Blair
- 1
Anthony K Blair Trading Performance
Anthony K Blair Ownership Network
Ownership Network List of Anthony K Blair
Ownership Network Relation of Anthony K Blair
Anthony K Blair Owned Company Details
What does Navidea Biopharmaceuticals Inc do?
Who are the key executives at Navidea Biopharmaceuticals Inc?
Anthony K Blair is the VP-Manufacturing & Operations of Navidea Biopharmaceuticals Inc. Other key executives at Navidea Biopharmaceuticals Inc include Chief Financial Officer Craig Dais , director & 10 percent owner Scott John K Jr. , and Chief Regulatory Officer Michel Mikhail .
Navidea Biopharmaceuticals Inc (NAVB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Navidea Biopharmaceuticals Inc (NAVB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Navidea Biopharmaceuticals Inc (NAVB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Navidea Biopharmaceuticals Inc (NAVB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Navidea Biopharmaceuticals Inc Insider Transactions
Anthony K Blair Mailing Address
Above is the net worth, insider trading, and ownership report for Anthony K Blair. You might contact Anthony K Blair via mailing address: Neoprobe Corporation, 425 Metro Place North #300, Dublin Oh 43017.